OSAM
IMNM icon

O'Shaughnessy Asset Management’s Immunome IMNM Stock Holding History

O'Shaughnessy Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,599
Closed -$54K – 2636
2021
Q1 		$54K Buy
+1,599
New +$39.7K ﹤0.01% 1381

Other funds holding IMNM

AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $244M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

O'Shaughnessy Asset Management's IMNM Position: Q2 2021 in Review

O'Shaughnessy Asset Management sold out of Immunome (IMNM) in Q2 2021, closing a stake of 1,599 shares — an estimated $54K sold.

O'Shaughnessy Asset Management first reported a position in IMNM in Q1 2021 and held it in 1 quarter. The position peaked at $54K in Q1 2021. 29 funds tracked by Wall St. Rank hold IMNM as of Q2 2021.

  • O'Shaughnessy Asset Management reported no remaining Immunome position as of Q2 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,599 Immunome shares in Q2 2021, an estimated $54K.
  • O'Shaughnessy Asset Management first reported a position in Immunome in Q1 2021 and held it in 1 quarter.
  • O'Shaughnessy Asset Management's Immunome position peaked at $54K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Immunome as of Q2 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.